Certara

???????? ?????????????? ?????? ???????????????????????? ???????? ??????????????????????. Certara is more than a technology and services provider—we’re your collaborator in forging a groundbreaking path forward in medicine. By uniting the fragmented processes of drug development, we empower life sciences organizations to make better, faster, and more informed decisions, transforming the lives of patients worldwide. Together, we can accelerate discovery, overcome urgent health challenges, and save not just days, but years in drug development. Join us and be part of a future where connected innovation changes everything. Check out our story on the new certara.com

We’re excited to announce Dr. Akiko Watanabe as one of our speakers at #Certainty by Certara in Philadelphia this May! ? Dr. Watanabe serves as the Director of the Clinical Pharmacology Department at Daiichi Sankyo Co. Ltd., where she has been involved in the planning of clinical trials and the support of regulatory submissions utilizing PBPK models, particularly in DDI, absorption, and special populations. She has successfully developed and submitted PBPK models for multiple drug applications to regulatory authorities. ? Dr. Watanabe will be presenting on "Regulatory Experience with PBPK in DDI Evaluation of a Novel TROP2-Directed Antibody-Drug Conjugate, Datopotamab Deruxtecan" on Day 1 of Certainty, May 7th. Don’t miss this chance to dive into the complexities of antibody-drug conjugates and their regulatory evaluation—register now to secure your seat at her session: https://lnkd.in/eNiTGkgn

What an incredible week of insightful discussions, exciting demos, and reconnecting with colleagues in the toxicology community. From our two engaging presentations to hands-on software demos and thought-provoking networking sessions, we truly enjoyed every conversation. A huge THANK YOU to everyone who stopped by our booth to chat, share ideas, and explore how Certara’s toxicology solutions are helping to advance safer and more effective drug development. Your curiosity and expertise made this event unforgettable! Missed us at SOT? No worries! You can still learn more about our cutting-edge toxicology services and products at certara.com. Until next year—see you at SOT 2026! ?? #SOT2025 #Toxicology #DrugDevelopment #PBPK #QST

?? ?????????????????????? ?????? ?????? ??????????????.?????? – ?????? ????????! ?? We’re excited to unveil our newly redesigned website, built to better serve the Certara community and showcase our impact in transforming the drug development paradigm. ? What’s new? ?? ?????? ?????????????????? ?????????? – Easily explore Solutions by Drug Development phase: https://lnkd.in/eTMmQ9dq ?? ???????????????? ???????????????? ?????????????? – Access a wealth of Certara’s knowledge, insights, and expertise: https://lnkd.in/ehp-Rtjb ?? ?????????????????????? ???????????????????? – Find the information you need, faster than ever: https://www.certara.com Whether you're looking for predictive modeling and simulation solutions, strategic regulatory guidance or clinical data solutions that accelerate decision-making, our new site makes it easier than ever to access the knowledge and tools that drive success in life sciences. Check it out today! ?? certara.com #Certara #DrugDevelopment #LifeSciences #PharmaInnovation #NewWebsite

Meet Himanshu M., Director of Business Development! At #SOT2025, he's showcasing #SecondaryIntelligence, #Simcyp PBPK Simulator & #Libra. ?? Hear his insights & catch up on the Simcyp V24 webinar: https://lnkd.in/ekpJA_37 Visit Booth #1147 to chat! #Simcyp #PBPK #Toxicology

It’s been an exciting day at #PHUSE US Connect! After a full day of engaging presentations, we’re now showcasing two posters during the Poster Session, which runs until 7 PM today! 1?? Elevate Your Game: Leveling Up SDTM Validation with the Magic of Data Managers 2?? Optimizing AI Software for Automated Protection of Personal and Commercially Sensitive Data If you're here, stop by and check out the work our team has been doing — we’d love to chat and answer any questions you may have! Don’t miss the chance to connect with us before the session wraps up!

?? SOT is buzzing! ?? Michael Miner caught up with Joyce (Chandler) Zandee on her event highlights. ?? Visit Booth #1147 to meet the team & get an exclusive look at the new SEND Explorer for data visualization! #SOT2025 #SENDExplorer #DataVisualization #Toxicology #Simcyp #Libra #CardiacSafety

?? Meet Marc Bailie! He’s been attending #SOT2025 and Michael Miner caught up with him to hear what he’s been up to at the event. If you are at SOT, swing by ?????????? ???????? to chat with Marc and the rest of our team. Don’t miss out on the opportunity to connect! See you there! #SOT2025 #Toxicology #SENDExplorer #Datasets

Join our upcoming Cambridge Healthtech Institute (CHI) webinar to discover how AI accelerates model development and enriches data, leading to more accurate model validation and faster decision-making. Certara experts Fran Brown, Piet Van Der Graaf, Ayman Akil, and Ian Kerman will explore AI's growing role in pharmaceutical development. From building models and linking to clinical endpoints, to applications of AI and regulatory insights, learn how to accelerate your drug development pipeline. ?? Register Now: https://lnkd.in/drJjyDvF #DrugDevelopment #AIinPharma #PharmaceuticalInnovation #Webinar #CambridgeHealthInstitute

Day 2 of SOT 2025 is off to an exciting start! We kicked off the day with a well-attended session where our very own Barira Islam teamed up with Sylvia. Escher (RISK-HUNT3R) and Nynke Kramer (ONTOX) to dive into the Challenges of NAM-Based Toxicokinetic Assessment in Regulatory Risk Assessment. They shared cutting-edge insights from ASPIS cluster research and a recent European Chemicals Agency project, including a tiered testing strategy within the ASPIS-initiated Alternative Safety Profiling Algorithm (ASPA). Check out these photos from yesterday and the energy our team brought to the conference! ???? #SOT2025 #NAMs #Toxicology #RiskAssessment #ASPIS #Innovation #Teamwork